Purchase Order 75D30124P00054
- Not listed
- Life Technologies Corporation, operating as Thermo Fisher Scientific, received a firm fixed-price purchase order award from the Centers for Disease Control and Prevention (CDC) Pittsburgh on August 5, 2024, valued at $18,854.28, with completion scheduled for September 30, 2024. The contract supports the development and validation of new HIV genotyping assays using Life Technologies thermal cyclers, which have been integrated into clinical monitoring tools for managing treatment in HIV-positive...
- The Centers for Disease Control and Prevention (CDC) awarded a $94,078.40 firm-fixed-price purchase order contract to Life Technologies Corporation, a subsidiary of Thermo Fisher Scientific, for the delivery of laboratory equipment. The contract has a performance period ending on May 11, 2023, and does not include a set-aside designation. Life Technologies Corporation is a leading provider of biomedical research and genetic analysis tools and technologies, supplying a wide range of specialized...
- Life Technologies Corporation has been awarded a $57,309.92 purchase order by the Department of Health and Human Services Centers for Disease Control and Prevention Pittsburgh. As the prime contractor, Life Technologies will provide products and services to support CDC programs through October 26, 2022. The pricing is firm fixed price. Life Technologies is a wholly owned subsidiary of Thermo Fisher Scientific, which provides scientific instruments and related services to various government...
- This is a $3,973,405.68 firm-fixed price contract awarded to Life Technologies Corporation, doing business as Thermo Fisher Scientific, by the Centers for Disease Control and Prevention (CDC) for the provision of Life Technologies supplies and reagents. The contract does not have a set-aside designation and runs through June 7, 2026. As a prime contractor, Life Technologies has previously supported federal initiatives related to healthcare, medical readiness, criminal investigations, food...
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a Firm Fixed Price BPA Call contract for $177,049.95 to Life Technologies Corporation, a for-profit manufacturer of scientific instruments, reagents, and consumables. The contract is for the delivery of laboratory supplies to support the CDC's mission in Grand Island, NY. Life Technologies Corporation is a division of the parent company Thermo Fisher Scientific, which has a history of providing...
- This federal contract award was made by the Centers for Disease Control and Prevention (CDC) to Life Technologies Corporation, a subsidiary of Thermo Fisher Scientific, for the provision of reagents and supplies. The $99,329.95 firm-fixed-price purchase order does not have a set-aside designation. Life Technologies Corporation has a history of serving as a prime contractor across various federal agencies, including the National Institutes of Health, Department of Defense, and Department of...
- This is a federal contract award to Life Technologies Corporation, a subsidiary of Thermo Fisher Scientific, by the Centers for Disease Control and Prevention (CDC) Pittsburgh office. The $138,750.00 firm fixed-price purchase order is for the delivery of laboratory equipment, with an ultimate completion date of August 21, 2016. The contract does not involve any set-aside designation. Life Technologies is an established provider of biomedical research and genetic analysis tools, supplying a...
- Life Technologies Corporation, a manufacturer of scientific instruments and reagents, has been awarded a $119,977.95 firm fixed price purchase order by the Centers for Disease Control and Prevention in Pittsburgh, Pennsylvania. The contract calls for the delivery of laboratory supplies to support the agency's research and public health initiatives. As a division of Thermo Fisher Scientific, Life Technologies utilizes three indefinite delivery vehicles with the National Institutes of Health,...
- The U.S. Department of Health and Human Services Centers for Disease Control and Prevention awarded a Blanket Purchase Agreement (BPA) call to Life Technologies Corporation, a for-profit manufacturer of scientific instruments, reagents, and consumables, for $249,498.40. This firm fixed-price contract is in support of the Coronavirus COVID-19 national interest action and will be performed in Grand Island, NY. Life Technologies, a division of Thermo Fisher Scientific, has extensive experience as a...
- This is a federal contract awarded by the Centers for Disease Control and Prevention (CDC) to Life Technologies Corporation, a subsidiary of Thermo Fisher Scientific Inc. The $80,127.45 firm-fixed-price purchase order is for the procurement of QuantStudio laboratory supplies. The contract does not have a set-aside designation. Life Technologies Corporation is a leading provider of biomedical research and genetic analysis tools and technologies to government agencies and academic institutions....
Life Technologies Corporation, a subsidiary of Thermo Fisher Scientific Inc. and headquartered in Grand Island, New York, was awarded a Purchase Order contract by the Centers for Disease Control and Prevention (CDC) Pittsburgh facility on July 31, 2024, with a ceiling value of $105,520.39 and ultimate completion date of August 2, 2024. The contract is issued on a firm fixed-price basis with no set-aside designation. According to the government description, the CDC conducted a competitive vendor analysis to determine whether similar reagents meeting the same performance specifications could be sourced from alternative vendors such as Fisher Scientific; however, the award to Life Technologies indicates the agency determined the company's offerings provided the required specialized capabilities for this procurement. Life Technologies maintains an extensive federal contracting presence across civilian agencies including the CDC, National Institutes of Health, Food and Drug Administration, and Department of Veterans Affairs, supplying specialized scientific instruments, reagents, consumables, and laboratory equipment that support life sciences research and public health missions. The company's product portfolio includes real-time polymerase chain reaction systems, sequencing kits, TaqMan reagents, immunoassay kits, and related molecular diagnostic supplies that have been critical to federal disease surveillance and COVID-19 response efforts. This purchase order represents a continuation of Life Technologies' ongoing role in supplying essential reagents and consumables to support CDC operations and public health initiatives.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Close Out | $0 | 2/17/26 | |
| Not listed | Not listed | $105.5k | 7/30/24 |